Latest Insights on IBB
![The banking boys are back in town today, as the FDIC prepares to ease financial-crisis era rules to pump up the market.](https://cdn.banyanhill.com/wp-content/uploads/2020/06/25135845/Great-Stuff-6-25-2020-Small.jpg)
June 25, 2020 Great Stuff
The Boys Are Back in Town Guess who just got back today? Them wild-eyed bankers that had been away. Haven’t changed that much to say. But man, I still think them banking cats are crazy. They were askin’ if credit default swaps were around — how they were, and where more derivatives could be found. […]![](https://cdn.banyanhill.com/wp-content/uploads/2020/06/23114112/shutterstock_1388871674-440x264.jpg)
June 23, 2020 2020 Financial Crisis, Big Picture. Big Profits., Stocks
[5-minute read] Stock prices will ultimately be decided by corporate earnings … and faith alone won’t save them from these headwinds.![Still betting against the Fed in this market? This billionaire hedge fund manager was humbled for doing just that.](https://cdn.banyanhill.com/wp-content/uploads/2020/06/08131314/Great-Stuff-6-08-2020-Small.jpg)
June 8, 2020 Great Stuff
Humbled By The Fed Hey, y’all … it’s Fed week! Are you ready? Are you pumped up to hear from the U.S. Federal Reserve on the state of the U.S. economy? Rarely will you see a stock market more excited about the prospect of the Fed doing absolutely nothing than this week. Economists expect Fed […]![](https://cdn.banyanhill.com/wp-content/uploads/2020/05/22100116/5-26-WID-Featured-Image-440x264.jpg)
May 26, 2020 American Investor Today, Investing, Seasonal Trends
(4-minute read) “Sell in May and go away” may not be the right advice this year. But even if it is, Chad Shoop has a recommendation to trade it.![I asked Brian Christopher to share his thoughts on what to expect going forward for this innovative pharmaceutical company.](https://cdn.banyanhill.com/wp-content/uploads/2020/05/22114725/pharma-powerhouse-440x264.jpg)
May 23, 2020 Investment Opportunities, Winning Investor Daily
I asked Brian Christopher to share his thoughts on what to expect going forward for this innovative pharmaceutical company.